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The objective of this study was to evaluate possible changes caused by multiple cocaine administration, 
alone and in combination with 1,4-dihydropiridine calcium channel blocker nifedipine, on cytochrome 
P450 levels both in the brain and liver. The experiment was done on male Wistar rats divided in four groups: 
control, treated with nifedipine (5 mg kg-1 i.p. for five days), treated with cocaine (15 mg kg-1 i.p. for five 
days), and treated with nifedipine and 30 minutes later with cocaine (also for five days). Total cytochrome 
P450 was measured spectrometrically in liver and brain microsomes. Multiple administration of cocaine 
alone and in combination with nifedipine did not change the brain P450 significantly. In the liver, nifedipine 
significantly increased P450 by 28 % vs. control. In contrast, cocaine significantly decreased P450 by 17 % 
vs. control. In animals treated with nifedipine and cocaine, cytochrome P450 increased 11 % (p<0.01) 
vs. control, decreased 12.5 % (p<0.001) vs. nifedipine group and increased 34 % (p<0.0001) vs. cocaine 
group. These results suggest that the cocaine and nifedipine interact at the metabolic level.
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Cocaine is an alkaloid psychostimulant with 
high addictive potential. It has a high affinity for 
the transporters of dopamine, serotonine and 
noradrenaline, and blocks their reuptake (1).
Cocaine is extensively metabolized in humans 
and animals by hepatic and plasma esterases to 
pharmacologically inactive benzoylecgonine, ecgonine 
methyl ester (2), and an active metabolite, norcocaine, 
the product of N-demethylation. Isoenzymes involved 
in cocaine N-demethylation show species differences. 
In humans and mice cocaine is N-demethylated by 
CYP 3A, and in rats by both CYP 3A and CYP 2B (3).
The involvement of CYP 3A4 in cocaine metabolism 
implies possible metabolic interactions with other 
substrates of this isoenzyme, including Ca2+ channel 
blockers nifedipine, nimodipine, and amlodipine (4). 
Literature data suggest that L-type calcium channels 
play a principal role in the regulation of adaptive 
changes in the central nervous system (5). Blockers 
of these channels are interesting for their potential 
application as anti-addiction agents, as they appear 
to play a principal role in the regulation of adaptive 
changes in the central nervous system by maintaining 
different types of drug dependence and withdrawal, 
including those induced by psyhostimulants (6). In 
our earlier studies (7) we have demonstrated that 
nifedipine, co-administered with morphine, attenuates 
the symptoms of opiate withdrawal that correlated with 
the changes in neuronal nitric oxide synthase (nNOS). 
At the same time we observed interactions between 
morphine and nifedipine in the liver.
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Since cocaine and the 1,4-dihydropyridine calcium 
blocker nifedipine are substrates of one and the same 
cytochrome P450 isoenzyme CYP 3A4, the aim of 
this study was to investigate possible P450-mediated 
interactions between the two compounds both at the 
hepatic and brain level.
MATERIALS AND METHODS
Animals
Male Wistar rats (weighing 200 g±10 g) were 
housed under standard laboratory conditions at 20 °C, 
with 12 h alternating light/dark cycles and free access 
to food and water. The animals were purchased from 
the National Breeding Centre, Slivnitza, Bulgaria. The 
principles stated in the European Convention for the 
Protection of Vertebrate Animals used for Experimental 
and other Scientific Purposes (ETS 123) (1991) (8) 
were strictly followed throughout the experiment.
Design of the experiment
The animals were divided into four groups (n=6 
each). The first group was receiving nifedipine at 
doses of 5 mg kg-1 i.p. once a day for five days (9). 
The second group was receiving 15 mg kg-1 i.p. of 
cocaine once a day for five days (10). The third group 
was receiving nifedipine (5 mg kg-1 i.p) and 30 min 
after that cocaine (15 mg kg-1 i.p.). This combination 
was also administered once a day for 5 days.
The fourth group included control, untreated 
animals, which were involved in the experiment 
from the very beginning and housed under the 
same standard laboratory conditions as the treated 
animals.
Biochemical parameters were evaluated 24 hours 
after the last administered dose.
Drugs used
The drugs used in this study were cocaine 
hydrochloride (Sigma, Germany) and nifedipine 
hydrochloride (Sigma, Germany).
Preparation of brain and liver microsomes for 
assessment of cytochrome P450
Freshly removed whole brains were rinsed with 
0.15 mol L-1 KCl three times and homogenised with 
nine volumes of Tris buffer, pH=7.4, according to 
the method of Bhagwat et al., (11). The livers were 
perfused with 0.15 mol L-1 KCl, excised and minced. 
The latter was homogenised with three volumes 
of 1.17 % KCl solution in a glass homogeniser, as 
described by Guengerich (12). The brain and liver 
homogenates were then centrifuged at 10,000 x g for 
20 min. The supernatant fractions were centrifuged 
at 105,000 x g for 60 min. The resulting microsomal 
pellets were stored at -20 °C until the assay. At the day 
of assay the microsomal pellets were resuspended 
and diluted in phosphate buffer + 1mmol L-1 EDTA 
(pH=7.4).
Cytochrome P450 was quant i f ied spe-
ctrophotometrically as a complex with CO, at
450 nm (13) and expressed in nmol/mg-1 protein 
(14).
Statistical analysis
The results are presented as mean values (±SD) 
of six animals per group. For the analysis we used 
Student’s t-test. Probability values less than 0.05 were 
considered significant.
RESULTS
Table 1 shows the effects of multiple administration 
of cocaine and nifedipine on the quantity of hepatic 
cytochrome P450. Both compounds, administered 
alone, influenced the enzyme quantity in a statistically 
significant fashion, as follows: nifedipine increased 
it by 28 % (p<0.001), while cocaine decreased it by 
17 % (p<0.001) vs. control. In the combination group 
the P450 quantity increased 11 % (p< 0.01) versus
control, decreased 12.5 % (p< 0.001) vs. nifedipine, 
and increased 34 % (p<0.0001) vs. cocaine group.
Table 2 shows changes in the quantity of cytochrome 
P450 in rat brain after multiple administration of 
cocaine and nifedipine. Both compounds, applied 
alone or in combination, did not significantly change 
the quantity of brain cytochrome P450.
DISCUSSION
L-type calcium channel blockers of the 
dihydropyridine class, such as nifedipine, nimodipine, 
amlodipine, have been reported to affect different 
types of drug dependence and withdrawal, including 
those to opioides (15), alcohol (16), psychostimulants 
(10). At the same time they are known to be the 
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substrates of one of the most abundant cytochrome 
P450 isoenzyme CYP3A that interacts with other 
substrates of this isoform, including cocaine.
Cocaine is a well-known and widespread 
psychostimulant; it causes behavioural changes, 
tolerance, and development of dependence. There 
is a close relationship between drug metabolism and 
dependence development. Haward et al. (17) studied 
the role of pharmacogenetically variable cytochrome 
P450 in drug abuse and dependence, and concluded 
that there are significant implications related to drug 
toxicity, drug-drug interactions, and abuse.
The objective of this study was to investigate 
the effects of multiple administration of cocaine, 
alone and in combination with nifedipine, on the 
quantity of cytochrome P 450 in rat liver and brain. 
Our results showed that in the liver, cocaine and 
nifedipine had the opposite effect; compared to the 
control, cocaine significantly reduced cytochrome P 
450, while nifedipine led to its statistically significant 
increase. Nifedipine is known to induce cytochrome P 
450 (18, 19). The available data on cocaine effects on 
drug-metabolising enzymes are controversial. Shuster 
at al. (20) focused on cocaine’s hepatotoxicity due to 
its metabolism. They presented evidence that cocaine 
administered chronically damaged the liver, and 
discussed the possibility that cocaine itself induced 
mixed-function oxidase in the smooth endoplasmic 
reticulum. Later studies have demonstrated that 
subacute cocaine treatment accounts for increased N-
hydroxilation of norcocaine in the mouse liver (21).
On the other hand, there are studies showing 
cocaine as an inhibitor of some polymorphic CYPs, 
such as CYP2D6 (17). The results of our study 
correlate with the results obtained by Pasanen et al. 
(22). They show that repeated cocaine administration 
for up to five days decreases CYP1A1/2, 2A4/5, 2Cx 
and 2E1-related enzyme activities.
In the combination group changes in P450 
quantity showed that neither nifedipine nor cocaine 
could exert their effects. These results could be 
explained by the metabolism of the compounds and 
their possible interactions on this level. Nifedipine has 
been reported to be the sustrate of cytochrome P450 
(CYP) 3A subfamily (4), and some of the administered 
cocaine is metabolised to the N-demethylated form, 
norcocaine, possibly by the same subfamily (2). Thus, 
these two compounds could be substrate competitors 
for CYP 3A, and this is one possible explanation of 
our results.
On the brain level, our results revealed that cocaine 
and nifedipine, alone and in combination, did not 
significantly change the quantity of cytochrome P450. 
It is known that the quantity of brain cytochrome is only 
about 3 % of that of the liver (11). Our data correlate 
with the results of Nabeshima T. et al. (23) who 
assessed the effects of morphine and phenobarbital 
on brain cytochrome P450. In view of its low brain 
levels, it is quite likely that brain cytochrome P450 
does not play a significant role in brain metabolism.
In conclusion, the changes in the quantity of 
liver cytochrome P450 observed in our study after 
Table 1 Quantity of cytochrome P450 in rat liver after multiple administration of cocaine and nifedipine







Control 0.346±0.022 100 - -
Nifedipine 0.439±0.007** 128 100 -
Cocaine 0.286±0.010** ++ 83 65 100
Nifedipine+ Cocaine 0.384 ±0.006* + # 111 87.5 134
*p < 0.01, **p < 0.001 vs. control
+p < 0.01; ++p < 0.001 vs. nifedipine group
#p < 0.0001 vs. cocaine group 
Table 2 Quantity of cytochrome P450 in rat brain after multiple administration of cocaine and nifedipine




Nifedipine + Cocaine 0.099 ±0.001 101
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multiple co-administration of nifedipine and cocaine 
suggest that these compounds mutually influenced 
each other’s metabolism, which led to changes in 
their pharmacokinetics. The influence on cocaine 
pharmacokinetics could affect the development of 
cocaine dependence and withdrawal syndrome, which 
is a matter of future investigations.
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Sa`etak
PROMJENE CITOKROMA P450 JETRE I MOZGA NAKON VI[EKRATNE PRIMJENE KOKAINA, SAMOG 
ILI U KOMBINACIJI S NIFEDIPINOM
Cilj je ovog istra`ivanja bio ocijeniti mogu}e promjene uzrokovane vi{estrukom primjenom kokaina kao 
jedinog agensa odnosno u kombinaciji s nifedipinom, 1,4-dihidropiridinskim blokatorom kalcijevih kanala, 
na razine citokroma P450 u mozgu i jetri {takora. @ivotinje (mu`jaci Wistar {takora) podijeljene su u ~etiri 
skupine: kontrolnu skupinu, skupinu koja je primala nifedipin (5 mg kg-1 ip. pet dana), skupinu koja je primala 
kokain (15 mg kg-1 ip. pet dana) i skupinu koja je primala nifedipin te pola sata kasnije kokain (tako|er pet 
dana). Ukupna koli~ina citokroma P450 mjerena je spektrofotometrijski u mikrosomima jetre i mozga. 
Vi{estruka primjena samo kokaina odnosno u kombinaciji s nifedipinom nije zna~ajno promijenila razine 
citokroma P450 u mozgu. U jetri je me|utim nifedipin u odnosu na kontrolnu skupinu uzrokovao povi{enje 
razina P450, za statisti~ki zna~ajnih 28 %. Kokain je uzrokovao statisti~ki zna~ajan pad razine P450 za 17 % u 
odnosu na kontrolnu skupinu. U ̀ ivotinja koje su primale kombinaciju nifedipina i kokaina razina citokroma 
P450 narasla je za 11 % (p<0.01) u odnosu na kontrolu, bila je 12.5 % (p<0.001) ni`a u odnosu na skupinu 
koja je primala nifedipin te vi{a za 34 % (p<0.0001) u odnosu na skupinu koja je primala samo kokain.
Rezultati ovog istra`ivanja upu}uju na interakcije ovih spojeva koje se odvijaju na razini metabolizma.
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